New hope for lung cancer patients whose disease returns after standard treatment
NCT ID NCT06680050
First seen Jan 10, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study is for people with stage III lung cancer whose tumor has come back in the chest after previous treatment with chemotherapy, radiation, and the drug durvalumab. Researchers want to see if giving radiation again followed by two drugs (durvalumab and ceralasertib) is safe and can help control the cancer. About 21 adults will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Grande Ospedale Metropolitano Niguarda
RECRUITINGMilan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
ASST degli Spedali Civili di Brescia
NOT_YET_RECRUITINGBrescia, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Azienda Ospedaliero - Universitaria di Parma
NOT_YET_RECRUITINGParma, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Azienda Ospedaliero Universitaria Careggi
RECRUITINGFlorence, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Azienda ospedaliera di Padova
NOT_YET_RECRUITINGPadova, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
IRCCS Ospedale Policlinico San Martino, Genova
RECRUITINGGenova, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Zurich
NOT_YET_RECRUITINGZurich, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital of Geneva
NOT_YET_RECRUITINGGeneva, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.